PDCD1 and colorectal carcinoma: Employing anti-PD-1 treatment in combination with vaccine inhibition of ARG1 synergistically impaired tumor growth and led to increased CD8+ T cell infiltration in mouse models of colorectal carcinoma and fibrosarcoma[156].